90 Diphtheria 931

Total Page:16

File Type:pdf, Size:1020Kb

90 Diphtheria 931 CHAPTER 90 Diphtheria 931 SUBSECTION III Gram-Positive Bacilli Diphtheria 90 Barbara W. Stechenberg Diphtheria is an acute infectious disease caused by Corynebacterium in mortality rates by a therapeutic intervention. In Germany alone, an diphtheriae or, less commonly, C. ulcerans. C. pseudotuberculosis, which estimated 45,000 lives were saved each year.62 primarily causes infections in sheep and goats, is not discussed here because it only rarely causes a diphtheria-like disease in humans. Infection by toxigenic strains of C. diphtheriae causes disease that is mediated by ETIOLOGY the production of an extracellular protein. Nontoxigenic strains also Corynebacteria (Klebs-Löffler bacilli) are irregularly staining, gram- can cause disease, but it is usually less severe. positive, nonmotile, nonsporulating, pleomorphic bacilli.54 The club- Before the discovery of antitoxin at the turn of the 20th century, shaped appearance of the bacillus is not a true morphologic feature, the “strangling angel of children,” as diphtheria once was called, was a but results from attempting to grow the bacillus on media that are significant cause of mortality in children and adults.108 Apparent reference nutritionally inadequate (Löffler media). The organism can be recovered to diphtheria can be traced to the 5th century BC in the works of Hip- most readily on media containing selective inhibitors that retard the pocrates, Epidemics III, case 7.79 In 1821, it was recognized as a specific growth of other microorganisms; a sheep blood agar–based medium entity by Brettoneau, who suggested that the disease was caused by a containing fosfomycin (for selectivity) and Tindale medium (tellurite germ and that it could be transmitted from person to person. Brettoneau medium with cystine) are ideal.43,44 C. diphtheriae and C. ulcerans coined the origin of the modern term diphtheria from the Greek root grow on supplement-free blood agar, chocolate agar, and other standard diphtheria, which means “skin” or “hide.”50 In 1883 the causative agent media.43 was identified by Klebs in stained smears from diphtheritic membranes; Colonies of C. diphtheriae (with the exception of the lipophilic, gray in 1884, Löffler grew the organism on artificial media and showed that C. intermedius) and C. ulcerans appear grayish white on Löffler medium. in guinea pigs it caused a fatal infection closely resembling human On tellurite medium, three diphtheria colony types can be distinguished: disease. mitis, gravis, and intermedius. Mitis colonies are smooth, black, and The toxin was purified in 1889 by Roux and Yersin, who found that convex; they do not ferment starch or glycogen and are hemolytic. toxin alone could cause the disease. Shortly thereafter, Behring and Gravis colonies are gray, radially striate, and semirough; they ferment Kitasato discovered antitoxins when they immunized animals with toxins starch and glycogen and usually are not hemolytic. Intermedius colonies rather than bacteria. The use of antitoxin to treat children with diphtheria are small and smooth and have a black center; they do not ferment at the turn of the 20th century resulted in one of the largest decreases starch or glycogen and are not hemolytic. C. ulcerans colonies resemble 932 SECTION 16 Bacterial Infections gravis on Tindale medium but differ in that they are hemolytic. Similar Diphtheria toxin is lethal to humans in an amount of approximately to gravis, they ferment starch and glycogen. All diphtheria biotypes and 130 µg/kg body weight. Cytoplasmic internalization of 1 molecule of C. ulcerans are characterized by cystinase activity and absence of pyra- toxin has been shown to cause cell death.11 Toxigenic and nontoxigenic zinamidase activity. C. ulcerans may be distinguished from C. diphtheriae strains of C. diphtheriae can cause disease, but only strains that produce by its urease activity and ability to liquefy gelatin. Biotype belfanti, toxin cause disease with symptoms of myocarditis and neuritis. which does not occur in a toxigenic form, may be distinguished from the three potentially toxigenic diphtheria biotypes by its inability to reduce nitrate on Tindale medium and from C. ulcerans by its lack of EPIDEMIOLOGY production of urease.43 Ribotyping and pulsed-field gel electrophoresis, Asymptomatic human carriers serve as the reservoir for C. diphtheriae. both of which involve restriction digestion of genomic bacterial DNA, Infection by C. diphtheriae is acquired by contact with either a carrier followed by gel electrophoresis and Southern blotting, permit more or an individual with active disease. The bacteria may be transmitted specific typing within each diphtheria biotype and aid in the epide- via droplets during coughing, sneezing, or talking. Rarely transmission miologic study of outbreaks.41,95 of C. diphtheriae occurs from skin lesions or fomites. Some reports C. diphtheriae biotypes intermedius, gravis, and mitis and C. ulcerans suggest that skin carriers of C. diphtheriae are more infectious than all have been observed in a toxigenic form. Intermedius was the biotype nose or throat carriers and that skin carriers may serve as potential isolated most commonly in the United States between 1971 and 1981. reservoirs for the initiation of epidemic spread.12,68 In areas in which Of the strains isolated, intermedius was found to be toxigenic more skin infections are endemic, levels of natural immunization may be often than mitis or gravis.36 In the United Kingdom between 1993 and high.20 This phenomenon is illustrated particularly well in a survey of 1998, and similarly in other parts of Europe, the biovar gravis has tetanus and diphtheria immunity in a rural Kenyan community, where represented most nontoxigenic isolates, followed by mitis and belfanti.45 age was not found to be predictive of immunity, and no correlation Of the four nontoxigenic isolates obtained during a surveillance study was found between levels of antibody for tetanus and diphtheria.77 of a U.S. Northern Plains Native American Community in 1996, two Person-to-person transmission of C. ulcerans is not known to occur, were of biotype mitis and two were gravis.59 According to a UK diphtheria although C. ulcerans was isolated from the siblings of two patients reference laboratory, between 1993 and 1998, the toxigenic isolates reported in the United Kingdom between 1995 and 1997.17 Cases of originating from Asia, Africa, and the Middle East were reported to be respiratory diphtheria caused by C. diphtheriae and C. ulcerans have of the biotype mitis or gravis, with the exception of one intermedius been documented in association with contaminated unpasteurized milk isolate.44 Golaz and associates59 reported similar findings when they taken from cows with infected teats.18,60,104 C. diphtheriae has been isolated surveyed the different biotypes in South Dakota. A significant overall from horses, dogs, and other domestic animals. C. ulcerans has been increase in the proportion of nontoxigenic isolates has been observed reported to infect ground squirrels in the United States, but transmission in Europe and Australia in recent years.58 The reason for this increase to humans has not been reported.67,93 C. ulcerans is a commensal in is unclear, but one hypothesis is that increased immunity to toxigenic animals and has been isolated in a wide range of wild and domestic strains secondary to immunization has altered this epidemiology. animals.105 The complete genome sequence of C. diphtheriae biotype gravis has According to World Health Organization (WHO) reports, diphtheria been elucidated.33 The genome is approximately 2.48 Mb with a G+C is distributed worldwide and remains endemic in many developing areas content of 53% and has approximately 2320 predicted coding sequences. of the world, including Asia, Africa, South America, and the Mediterranean Metabolic analysis of the genome has revealed that C. diphtheriae has regions.19 Worldwide, diphtheria epidemics have occurred in a cyclic a complete set of enzymes for glycolysis, gluconeogenesis, pentose- manner since the 16th century. In 2014, 7321 cases of diphtheria were phosphate pathways, anaerobic and aerobic respiration, amino acid reported to the WHO, although many others were likely unreported. biosynthesis, and purine nucleotide biosynthetic pathway. Most of the In the United States, the incidence and mortality rates from diphtheria enzymes for the tricarboxylic acid cycle are present, with the exception in the 1920s were 140 to 150 cases/100,000, with 13,000 to 15,000 deaths of an enzyme succinyl coenzyme A (CoA) synthetase that catalyzes the each year. The number of cases gradually declined to 15 cases/100,000 conversion of succinate to succinyl CoA. An alternative enzyme present population in 1945 with the extensive use of diphtheria toxoid vaccine. in C. diphtheriae may fulfill this conversion, however. The pyrimidine From 1970 through 1979, the average number of cases of diphtheria pathway in C. diphtheriae lacks an enzyme that interferes with the reported annually in the United States was 196.8 From 1980 to 2004, production of cytidine; the pathway to the biosynthesis of thymidine only 57 cases of diphtheria were reported in the United States. Approxi- is complete. The genome has revealed 13 regions that are unique to C. mately 75% of the cases were in patients older than 15 years who were diphtheriae and may serve as pathogenicity islands.33 unimmunized or inadequately immunized.8 Only two cases of diphtheria No functional or significant differences have been
Recommended publications
  • Immune Effector Mechanisms and Designer Vaccines Stewart Sell Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY, USA
    EXPERT REVIEW OF VACCINES https://doi.org/10.1080/14760584.2019.1674144 REVIEW How vaccines work: immune effector mechanisms and designer vaccines Stewart Sell Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY, USA ABSTRACT ARTICLE HISTORY Introduction: Three major advances have led to increase in length and quality of human life: Received 6 June 2019 increased food production, improved sanitation and induction of specific adaptive immune Accepted 25 September 2019 responses to infectious agents (vaccination). Which has had the most impact is subject to debate. KEYWORDS The number and variety of infections agents and the mechanisms that they have evolved to allow Vaccines; immune effector them to colonize humans remained mysterious and confusing until the last 50 years. Since then mechanisms; toxin science has developed complex and largely successful ways to immunize against many of these neutralization; receptor infections. blockade; anaphylactic Areas covered: Six specific immune defense mechanisms have been identified. neutralization, cytolytic, reactions; antibody- immune complex, anaphylactic, T-cytotoxicity, and delayed hypersensitivity. The role of each of these mediated cytolysis; immune immune effector mechanisms in immune responses induced by vaccination against specific infectious complex reactions; T-cell- mediated cytotoxicity; agents is the subject of this review. delayed hypersensitivity Expertopinion: In the past development of specific vaccines for infections agents was largely by trial and error. With an understanding of the natural history of an infection and the effective immune response to it, one can select the method of vaccination that will elicit the appropriate immune effector mechanisms (designer vaccines). These may act to prevent infection (prevention) or eliminate an established on ongoing infection (therapeutic).
    [Show full text]
  • Medical Bacteriology
    LECTURE NOTES Degree and Diploma Programs For Environmental Health Students Medical Bacteriology Abilo Tadesse, Meseret Alem University of Gondar In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education September 2006 Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00. Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education. Important Guidelines for Printing and Photocopying Limited permission is granted free of charge to print or photocopy all pages of this publication for educational, not-for-profit use by health care workers, students or faculty. All copies must retain all author credits and copyright notices included in the original document. Under no circumstances is it permissible to sell or distribute on a commercial basis, or to claim authorship of, copies of material reproduced from this publication. ©2006 by Abilo Tadesse, Meseret Alem All rights reserved. Except as expressly provided above, no part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission of the author or authors. This material is intended for educational use only by practicing health care workers or students and faculty in a health care field. PREFACE Text book on Medical Bacteriology for Medical Laboratory Technology students are not available as need, so this lecture note will alleviate the acute shortage of text books and reference materials on medical bacteriology.
    [Show full text]
  • Module 2: Diphtheria
    The Immunological Basis for Immunization Series Module 2: Diphtheria DEPARTMENT OF VACCINES AND BIOLOGICALS ~-) World Health Organization ~ ~ fJ! Geneva ----~ WHO/EPI/GEN/93.12 ORIGINAL: ENGLISH DISTR.: GENERAL The Immunological Basis for Immunization Series Module 2: Diphtheria Dr Artur M. Galazka Medical Officer Expanded Programme on Immunization DEPARTMENT OF VACCINES AND BIOLOGICALS .) World Health Organization ~ , ~ ~ Geneva ~ I iJff 2001 ~~ The Department of Vaccines and Biologicals thanks the donors whose unspecified financial support has made the production of this document possible. United Nations Development Fund (UNDP) The Rockefeller Foundation The Government of Sweden The Immunological Basis for Immunization series is available in English and French (from the address below). It has also been translated by national health authorities into a number of other languages for local use: Chinese, Italian, Persian, Russian, Turkish, Ukranian and Vietnamese. The series comprises eight independent modules: Module 1: General immunology Module 2: Diphtheria Module 3: Tetanus Module 4: Pertussis Module 5: Tuberculosis Module 6: Poliomyelitis Module 7: Measles Module 8: Yellow fever Produced in 1993 Reprinted (with new covers but no changes to content) in 2001 Ordering code: WHO/EPI/GEN/93.12 This document is available on the Internet at: www.who.int/vaccines-documents/ Copies may be requested from: World Health Organization Department of Vaccines and Biologicals CH-1211 Geneva 27, Switzerland • Fax: + 41 22 791 4227 • £-mail: [email protected] • ©World Health Organization 2001 This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes.
    [Show full text]
  • Manual for Quality Control of Diphtheria, Tetanus and Pertussis Vaccines
    WHO/IVB/11.11 Manual for Quality Control of Diphtheria, Tetanus and Pertussis Vaccines Immunization, Vaccines and Biologicals WHO/IVB/11.11 Manual for Quality Control of Diphtheria, Tetanus and Pertussis Vaccines Immunization, Vaccines and Biologicals The Department of Immunization, Vaccines and Biologicals thanks the donors whose unspecified financial support has made the production of this document possible. This document was published by the Expanded Programme on Immunization (EPI) of the Department of Immunization, Vaccines and Biologicals Ordering code: WHO/IVB/11.11 Printed: April 2013 This publication is available on the Internet at: www.who.int/vaccines-documents/ Copies of this document as well as additional materials on immunization, vaccines and biologicals may be requested from: World Health Organization Department of Immunization, Vaccines and Biologicals CH-1211 Geneva 27, Switzerland • Fax: + 41 22 791 4227 • Email: [email protected] • © World Health Organization 2013 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 3264; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
    [Show full text]
  • Simple Serological Techniques"
    LECTURE: 26 Title SIMPLE SEROLOGICAL LABORATORY TECHNIQUES LEARNING OBJECTIVES: The student should be able to: • Define the term "simple serological techniques". • Describe the benefit of the use of serological tests. • Define the term "titer". • Enumerate the environmental factors affecting the ag-ab interactions. • Enumerate the different immunological names give to antibodies. • Define the terms; prozone, equivalnce zone, and post zone. • Enumerate some examples of the major simple serological techniques, such as: - Agglutination reactions - Precipitation reactions • Explain the principle of the agglutination reactions • Enumerate some diagnostic test depend on the principle the of the agglutination reactions. • Explain the principle of the precipitation reactions • Enumerate some diagnostic test depend on the principle of the precipitation reaction. • Explain the terms; lattice, cross-reacting antibodies. Latex, charcoal, and agar. • Discuss the identity, partial identity, and non-identity • Compare between agglutination and precipitation reactions. • Explain the Immunodiffusion (single and double diffusion) methods (Ouchterlony technique). • Explain the principle of the toxin-anti-toxin reaction. • Explain the term "flocculation reaction". LECTURE REFRENCE: 1. TEXTBOOK: ROITT, BROSTOFF, MALE IMMUNOLOGY. 6th edition. Chapter 27. pg. 417-434. 2. TEXTBOOK: MARY LOUISE TURGEON. IMMUNOLOGY & SEROLOGY. IN LABORATORY MEDICINE. 2ND EDITION. Chapter 6. pg 111-131. 3. TEXTBOOK: ABUL K. ABBAS. ANDREW H. LICHTMAN. CELLULAR AND MOLECULAR IMMUNOLOGY. 5TH EDITION. pg 522-534. 1 SIMPLE LABORATORY METHODS I. GENERAL CONSIDERATIONS Serologic reactions that are in vitro Antigen-antibody reactions provide methods for the diagnosis of disease and for the identification and quantitation of antigens and antibodies. Simple serological techniques are called simple, because, these procedures involving direct demonstration and observation of reactions, they do not require the participation of accessory factors such as; indicator system, or specialized equipment.
    [Show full text]
  • The Use of Transfer Factor in a Patient with Agammaglobulinemia
    TRANSFER FACTOR IN AGAMMAGLOBULINEMIA 54 1 41. Murphy, B. E. P.: Some studies of the protein-binding of steroids and their (1972). application to the routine micro and ultramicro measurement of various 54. Tietze, H. U., Zurbriigg, R. P.. Zuppinger. K. A,, Joss. E. E.. and KZser, H.: steroids in body nuids by competitive protein-binding radioassay. J. Clin. Occurrence of impaired cortisol regulation in children with hypoglycemia Endocrinol. Metab.. 27: 973 (1967). associated with adrenal medullary hyporesponsiveness. J. Clin. Endocrinol. 42. Nelson, N.: A photometric adaptation of the Somogyi method for the determina- Metab., 34: 948 (1972). tion of glucose. J. Biol. Chem., 153: 375 (1944). 55. Unger, R. H.: High growth-hormone levels in diahet~cketoacidosis: A possible 43. Outschoorn. A. S.: The hormones of the adrenal medulla and their release. Brit. cause of insulin resistance. J. Amer. Med. Ass.. 191: 945 (1965). J. Pharmacol.. 7: 605 (1952). 56. Voorhess. M. L.: Urinary catecholamine excretion by healthy children. I. Daily 44. Perkoff, G. T., and Tyler, F. H.: Paradoxical hyperglycemia In diabetic patients excretion of dopamine, norepinephrine, epinephrine and 3-methoxy-4- treated with insulin. Metabolism, 3: 110 (1954). hydroxymandelic acid. Pediatrics, 39: 252 (1967). 45. Roth. J.. Glick, S. M., Yalow. R. S., and Berson, S. A,: Hypoglycemia: A potent 57. Wallace. J. M.. and Harlan. W. R.: Significance of epinephrine in insulin stimulus to secretion of growth hormone. Science, 140: 987 (1963). hypoglycemia in man. Amer. J. Med., 38: 531 (1965). 46. Sabeh, G., Mendelsohn, L. V.. Corredor, D. G.. Sunder, J. H., Friedman, L. M., 58.
    [Show full text]
  • Seminars in Immunology
    SEMINARS IN IMMUNOLOGY SEMINARS IN IMMUNOLOGY Edited by András Kristóf Fülöp Written and translated by Éva Pállinger Edit Buzás András Falus György Nagy Marianna Csilla Holub Sára Tóth László Kőhidai Zsuzsanna Pál Scientific reviewers Edit Buzás András Falus English proofreading Adrienn Ádám Semmelweis University • Budapest, 2012 © András Kristóf Fülöp, 2012 2 Manuscript closed on 31 May 2012 ISBN 978-963-9129-82-5 Semmelweis University Responsible for publishing: Semmelweis University Editor: András Kristóf Fülöp Technical editor: Adrienn Ádám Length: 223 pages 3 CONTENTS 1. INTRODUCTION (ÉVA PÁLLINGER) ......................................................................................................... 10 1.1. Basic terms ..................................................................................................................................... 10 1.1.1. Innate and acquired immunity ......................................................................................................... 10 1.1.2. What does the immune system recognize? .................................................................................... 11 1.1.3. What types of receptors can recognize antigens? .......................................................................... 11 1.1.3.1. PRR (pattern recognition receptors, pathogen recognition receptors) ............................................ 11 1.1.3.2. T cell receptor (TCR) ......................................................................................................................
    [Show full text]
  • Wiskott-Aldrich Syndrome, a Genetically Determined Cellular Immunologic Deficiency: Clinical and Laboratory Responses to Therapy with Transfer Factor* A
    Proceedings of the National Academy of Sciences Vol. 67, No. 2, pp. 821-828, October 1970 Wiskott-Aldrich Syndrome, A Genetically Determined Cellular Immunologic Deficiency: Clinical and Laboratory Responses to Therapy with Transfer Factor* A. S. Levint, L. E. Spitlert, D. P. Stites, and H. H. Fudenberg§ DEPARTMENT OF PEDIATRICS AND SECTION OF HEMATOLOGY AND IMMUNOLOGY, DEPARTMENT OF MEDICINE, UNIVERSITY OF CALIFORNIA MEDICAL CENTER, SAN FRANCISCO, CALIFORNIA 94122 Communicated by Daniel E. Koshland, June 8, 1970 Abstract. Patients with diseases associated with defects in cellular immunity, such as the Wiskott-Aldrich syndrome, characteristically have severe recurrent infections and usually succumb to overwhelming infection at an early age. This communication describes a patient with this syndrome, defective delayed hypersensitivity by skin tests and by in vitro lymphocyte response, who was treated with dialysate of peripheral blood leukocytes (transfer factor). After treatment, the clinical status of the patient improved dramatically, concomitant with the development of delayed hypersensitivity to antigens to which the donor was sensitive. In vitro tests after transfer indicated that the patient's lympho- cytes, when stimulated by specific antigen, produced migration inhibitory factor without concomitant DNA synthesis. These observations dissociate skin test sensitivity and activity of migration inhibitory factor from in vitro blastogenesis. Further, the response to phytohemagglutinin remained diminished before and after therapy. While
    [Show full text]
  • Special Bacteriology Basic Laboratory Tests
    2016 UNIVERZITA KOMENSKÉHO V BRATISLAVE JESSENIOVA LEKÁRSKA FAKULTA V MARTINE Jana KOMPANÍKOVÁ Martina NEUSCHLOVÁ Vladimíra SADLOŇOVÁ SPECIAL BACTERIOLOGY BASIC LABORATORY TESTS Preface Special Bacteriology – Basic Laboratory Tests is intended above all for medical students. The book includes standard procedures commonly used in microbiological laboratory. We have tried to present principles of laboratory tests to make them easier to understand. Authors Contents 1 STAPHYLOCOCCI ........................................................................................................ 5 1.1 GRAM STAIN ................................................................................................................... 7 1.2 STAPHYLOCOCCI - BLOOD AGAR CULTURE .................................................................... 7 1.3 CATALASE TEST ............................................................................................................... 8 1.4 MANNITOL SALT AGAR CULTURE ................................................................................... 9 1.5 COAGULASE TEST ......................................................................................................... 11 2 STREPTOCOCCI ........................................................................................................ 14 2.1 STREPTOCOCCI - GRAM STAIN ..................................................................................... 15 2.2 STREPTOCOCCI - BLOOD AGAR CULTURE ....................................................................
    [Show full text]
  • 19 Diphtheria Toxoid Tejpratap S.P
    19 Diphtheria Toxoid Tejpratap S.P. Tiwari and Melinda Wharton Respiratory diphtheria is an acute communicable upper respi- Schick introduced a skin test for immunity that consisted of the ratory illness caused by toxigenic strains of Corynebacterium injection of a small, measured amount of diphtheria toxin; in diphtheriae, a Gram-positive bacillus. The illness is character- immune persons, circulating antibody neutralized the toxin, ized by a membranous inflammation of the upper respiratory and no local lesion was observed.2 The Schick skin test was tract, usually of the pharynx but sometimes of the posterior widely used to distinguish immune individuals and target nasal passages, larynx, and trachea, and by widespread damage immunization to those susceptible. In the early 1920s, Ramon to other organs, primarily the myocardium and peripheral showed that diphtheria toxin, when treated with heat and for- nerves. Extensive membrane production and organ damage malin, lost its toxic properties but retained its ability to produce are caused by local and systemic actions of a potent exotoxin serologic protection against the disease. Thus the current produced by toxigenic strains of C. diphtheriae. A cutaneous immunizing preparation, diphtheria toxoid, came into being.6 form of diphtheria commonly occurs in warmer climates or tropical countries. WHY THE DISEASE IS IMPORTANT HISTORY OF THE DISEASE Before the introduction of diphtheria immunization, diphthe- ria was a major cause of childhood mortality, and it remains Historical descriptions of
    [Show full text]
  • Antibody Mediated Neutralization Cytolytic/Cytotoxic Immune Complex Anaphylactic
    OUTLINE Introduction Antibody Mediated Neutralization Cytolytic/Cytotoxic Immune Complex Anaphylactic Cell Mediated T-cell Cytotoxic (Killer T-cells) Delayed Hypersensitivity Antibody or Cell Mediated Granulomatous Reactions IMMUNE EFFECTOR MECHANISMS LEVELS OF REACTIONS OF ANTIGEN WITH ANTIBODY OR CELLS PRIMARY SECONDARY TERTIARY REACTION REACTION REACTION in vitro in vivo ANTIBODY MEDIATED INACTIVATION NEUTRALIZATION AGGLUTINATION, LYSIS CYTOLYTIC REACTIONS OPSONIZATION Ag+Ab AgAb IMMUNE COMPLEX PRECIPITATION REACTIONS MAST CELL ANAPHYLACTIC DEGRANULATION REACTIONS CELL MEDIATED DELAYED T-DTH HYPERSENSITIVITY LYMPHOKINES REACTIONS +Ag-> MACROPHAGE ACTIVATION BLAST CELL TRANSFORMATION T-CTL TARGET-CELL LYSIS DESTRUCTION Ab or + INSOLUBLE ANTIGEN GRANULOMA NEUTRALIZATION/INACTIVATION REACTIONS PROTECTIVE REACTIONS TOXIN NEUTRALIZATION DIPHTHERIA,, TETANUS, ANTHRAX, CHOLERA RECEPTOR BLOCKADE PERTUSSIS VIRUSES MEASLES. FLU, POLIO, HEPATITIS, PAPILLOMA, ETC. PASSIVE ANTIBODY TREATMENT – CHOLERA, EBOLA VIRUS DESTRUCTIVE REACTIONS DIABETES, HEMOPHILIA, APLASTIC ANEMIA, MYASTHENIA GRAVIS, GRAVE’S DISEASE, BULLOUS SKIN DISEASES EVIDENCE FOR NEUTRILIZING ANTIBODIES DICK AND SCHICK TESTS PEOPLE WHO RECOVER FROM STREPTOCOCCAL OR DIPHTHERIA INFECTION HAVE NO REACTION TO SKIN INJECTION OF TOXIN DUE TO PRODUCTION OF NEUTRALIZING ANTIBODY SCARLET FEVER GROUP A STREPTOCOCCUS TOXIN Sequella: Glomerulonephritis; Rheumatic heart disease (IMMUNE COMPLEX REACTION) VACCINE UNDER DEVELOPMENT TREATED WITH ANTIBOTICS PENICILLIN OR AMOXICILLIN Dale JB, et al,
    [Show full text]
  • Special Microbiology for Dummies
    STAPHYLOCOCCAL & STREPTOCOCCAL INFECTIONS Staphylococcal infection Streptococcal infections Definition an infection caused by pathogenic bacteria of one of an infection caused by pathogenic bacteria of one of several several species of the genus Staphylococcus or their toxins. species of the genus Streptococcus or their toxins. Almost any Almost any organ of the body may be involved. The organ of the body may be involved. The infections occur in infections occur in many forms, including meningitis, many forms, including cellulitis, endocarditis, erysipelas, pneumonia, tonsillitis, urinary tract infection impetigo, meningitis, pneumonia, scarlet fever, tonsillitis, and urinary tract infection. Etiology Family - Micrococcaceae Family - Streptococcaceae Genus -Staphylococcus Genus -Streptococcus Species: S. aureus, S. epidermidis, Species: Str. pyogenes, Str. pneumoniae S. saprophyticus. Morphology Gram-positive Gram-positive Spherical cell shape Spherical cell shape Nonmotile (non flagellated) Nonmotile (non flagellated) Non spore forming Non spore forming non capsulated (rare strains are capsulated) capsulated or non capsulated Arranged in grape-like clusters (staphyle means bunch of Arranged in pairs or in chains (chain formation is due to the grapes and this arrangement is due to the tendency of the cocci dividing in one plane only and the daughter cells failing organism to divide in different planes) to separate completely). Epidemiology Source of infection: sick people, and staph carriers. Source of infection: sick people, and Streptococcus Mode of transmission: direct or indirect contact with a carriers person who has a discharging would, a clinical infection of Mode of transmission: direct or indirect contact with a person the respiratory or urinary tract, or one who is colonised who has a discharging would, a clinical infection of the with the organism.
    [Show full text]